Discontinued — last reported Q1 '18
UL Solutions Allowance for Doubtful Accounts Receivable (Current) remained flat by 0.0% to $12.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $12.00M to $12.00M. Over 2 years (FY 2023 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows an upward trend with a 15.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_current| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.00M | $11.00M | $12.00M | $11.00M | $9.00M | $12.00M | $13.00M | $13.00M | $12.00M | $12.00M |
| QoQ Change | — | +22.2% | +9.1% | -8.3% | -18.2% | +33.3% | +8.3% | +0.0% | -7.7% | +0.0% |
| YoY Change | — | — | — | — | +0.0% | +9.1% | +8.3% | +18.2% | +33.3% | +0.0% |